Evaluating the Impact of Cross-over from Imatinib to Nilotinib on the Overall Survival in Chronic Myeloid Leukemia Using Inverse Probability of Censoring Weighting: Results from the Gimema Sustrenim Study
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Alfonso Piciocchi, Giovanni Marsili, Ylenia Belperio, Monica Messina, Francesca Paola Paoloni, Stefano Soddu, Isabella Capodanno, Rosaria Sancetta, Elisabetta Abruzzese, Alessandro Pulsoni, Monia Lunghi, Giovanni Caocci, Fausto Castagnetti, Paola Fazi, Marco Vignetti, Massimo Breccia, Fabrizio Pane
Institutions: Fondazione Gimema Onlus, Sapienza University of Rome, Azienda Sanitaria Unità Locale di Reggio Emilia, Ospedale dell' Angelo, St. Eugenio Hospital, Ospedale Santa Maria Goretti, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, University of Cagliari, Istituto di Ematologia di Bologna, University of Bologna, Policlinico Umberto I, Federico II University Hospital, University of Naples Federico II
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405038359